DrKu.io® / About
DrKu.io® is being developed beyond a founder-centric model — toward a durable platform for intellectual property, technical knowledge, validation evidence and commercial relationships.
FOUNDER • INDEPENDENT RESEARCH FOUNDATIONS • CONTACT
Dr. Ho Wa KU founded DrKu.io® to develop, protect and commercialise technologies concerned with verifiable execution, cyber-physical systems and the boundary between digital decisions and consequential real-world effects.
DrKu.io is intentionally being developed beyond a founder-centric model.
Its long-term objective is to create a durable platform in which intellectual property, technical knowledge, validation evidence and commercial relationships can be developed systematically and scaled through teams, partnerships and future ventures.
These programmes and resources maintain distinct research or specialist positioning. They are not DrKu.io commercial products, and no subsidiary, ownership, endorsement, or organisational relationship is implied unless expressly stated.
Independent public research into the wider end-to-end consequential-system problem space spanning evidence, governing context, authority, execution, realized effect, and subsequent proof, recovery or reconciliation.
EvidenceToEffect is related to DrKu.io engineering work but is not a DrKu.io commercial product or subsidiary.
The canonical research home of the publicly articulated Execution Governance programme, examining whether consequential actions have current authority to proceed under applicable constraints and live conditions.
Execution Governance is an independent research programme and is not a DrKu.io commercial product.
18031CRA.com is a specialist CRA research and engineering resource. Its own site identifies DrKu Technology Limited as its operator.
18031CRA.com is maintained as a specialist research and engineering resource rather than as a DrKu.io product website.
These programmes are independent research resources. They are not depicted as DrKu.io subsidiaries.
Separate enquiry routes are maintained for patent and licensing, technology partnership, strategic investment and research collaboration. Please use the corresponding route so your enquiry reaches the right contact at DrKu.io.
Licensing, field-of-use and patent portfolio enquiries.
contact@drku.ioPartnership, joint development and technology transfer discussions.
partners@drku.ioStrategic capital and institution-ready platform discussions.
partners@drku.ioResearch collaboration and confidential technical discussion.
contact@drku.ioPublic materials are non-confidential. Detailed technical, IP and validation information may be shared selectively after appropriate qualification and confidentiality arrangements.